Trade Replimune - REPL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 14.28 |
| Open | 14.52 |
| 1-Year Change | 91.81% |
| Day's Range | 13.58 - 14.62 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 13.93 | -0.65 | -4.46% | 14.58 | 14.72 | 13.55 |
| Feb 20, 2025 | 14.28 | 0.60 | 4.39% | 13.68 | 14.72 | 13.38 |
| Feb 19, 2025 | 13.73 | 0.11 | 0.81% | 13.62 | 14.39 | 13.62 |
| Feb 18, 2025 | 13.97 | 0.00 | 0.00% | 13.97 | 14.25 | 13.70 |
| Feb 14, 2025 | 14.07 | -0.15 | -1.05% | 14.22 | 14.54 | 14.03 |
| Feb 13, 2025 | 14.26 | 0.86 | 6.42% | 13.40 | 14.40 | 13.31 |
| Feb 12, 2025 | 13.76 | 1.45 | 11.78% | 12.31 | 13.82 | 12.31 |
| Feb 11, 2025 | 12.78 | -0.03 | -0.23% | 12.81 | 12.96 | 12.50 |
| Feb 10, 2025 | 13.08 | -0.39 | -2.90% | 13.47 | 13.89 | 13.03 |
| Feb 7, 2025 | 13.90 | -0.07 | -0.50% | 13.97 | 13.99 | 13.44 |
| Feb 6, 2025 | 14.01 | -0.21 | -1.48% | 14.22 | 14.31 | 13.80 |
| Feb 5, 2025 | 14.22 | 0.27 | 1.94% | 13.95 | 14.37 | 13.73 |
| Feb 4, 2025 | 13.97 | 0.40 | 2.95% | 13.57 | 14.07 | 13.33 |
| Feb 3, 2025 | 13.66 | 0.13 | 0.96% | 13.53 | 14.04 | 13.28 |
| Jan 31, 2025 | 13.91 | 0.34 | 2.51% | 13.57 | 14.46 | 13.37 |
| Jan 30, 2025 | 13.57 | -0.40 | -2.86% | 13.97 | 14.31 | 13.48 |
| Jan 29, 2025 | 14.01 | 0.51 | 3.78% | 13.50 | 14.54 | 13.50 |
| Jan 28, 2025 | 13.97 | 0.57 | 4.25% | 13.40 | 14.14 | 13.40 |
| Jan 27, 2025 | 13.64 | 0.40 | 3.02% | 13.24 | 14.08 | 13.01 |
| Jan 24, 2025 | 13.56 | -0.04 | -0.29% | 13.60 | 13.64 | 12.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Replimune Company profile
About Replimune Group Inc
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP1 (vusolimogene oderparepvec), RP2, and RP3. The Company is focused on Phase 2 clinical trials with its lead product candidate, RP1, in approximately 240 patients with a range of solid tumors.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Replimune Group Inc revenues was not reported. Net loss increased 45% to $86.3M. Higher net loss reflects Research and development increase of 41% to $49.7M (expense), Stock-based Compensation in SGA increase from $4.6M to $12M (expense), General and administrative increase of 38% to $16.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.34 to -$1.66.
| Industry: | Biotechnology & Medical Research (NEC) |
500 Unicorn Park Dr
WOBURN
MASSACHUSETTS 01801-3377
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com